Corcept Therapeutics Incorporated
Last updated September 27, 2026
Organization details
- Legal name
- Corcept Therapeutics Incorporated
- Ownership
- Public
- Status
- Active
- Headquarters country
- United States
- Ticker symbol
- CORT
- Primary stock exchange
- Nasdaq
Identifiers
- SEC CIK
- 0001088856
Board of directors
-
Daniel N. Swisher Jr. · DirectorSince 2023
-
David L. Mahoney · DirectorSince 2023
-
G. Leonard Baker Jr. · DirectorSince 2023
-
Gillian Cannon · DirectorSince 2023
-
Gregg H. Alton · DirectorSince 2023
-
James N. Wilson · DirectorSince 2023
-
Joseph K. Belanoff · Director · Chief Executive OfficerSince 2023
-
Joshua M. Murray · DirectorSince 2023
-
Kimberly Park · DirectorSince 2023
Chief executives
Joseph K. Belanoff
· Chief Executive Officer
Dates unknown
Board connections
4 of this board's directors also sit on 6 other boards.
- via Joshua M. Murray
- via Daniel N. Swisher Jr.
- via Gregg H. Alton
- via Gregg H. Alton
- via Daniel N. Swisher Jr.
- via Gillian Cannon
Insider trades
All notable trades →From SEC Forms 4 and 5. Open-market purchases and sales are highlighted; grants, option exercises and shares withheld for tax are routine.
- Bought, last 12 months
- $0
- 0 purchases by 0 insiders
- Sold, last 12 months
- $0
- 0 sales by 0 insiders
| Date | Insider | Transaction | Shares | Price | Value |
|---|---|---|---|---|---|
| Mar 24, 2025 | Lyon Joseph Douglas Officer (See Remarks) | Option exercise | +421 | $13.56 | $5,709 |
| Mar 24, 2025 | Joseph K. Belanoff Director, Officer (Chief Executive Officer) | Open-market sale | −1,974 | $60.83 | $120,078 |
| Mar 24, 2025 | Maduck Sean Officer (See Remarks) | Option exercise | +1,697 | $5.05 | $8,570 |
| Mar 24, 2025 | Lyon Joseph Douglas Officer (See Remarks) | Open-market sale | −421 | $60.58 | $25,504 |
| Mar 24, 2025 | Maduck Sean Officer (See Remarks) | Open-market sale | −1,697 | $60.58 | $102,804 |
| Mar 20, 2025 | Robb Gary Charles Officer (Chief Business Officer) | Gift | +233 | — | — |
| Mar 20, 2025 | Robb Gary Charles Officer (Chief Business Officer) | Gift | +233 | — | — |
| Mar 12, 2025 | Robb Gary Charles Officer (Chief Business Officer) | Gift | −4,625 | — | — |
| Mar 12, 2025 | Robb Gary Charles Officer (Chief Business Officer) | Gift | +1,000 | — | — |
| Mar 12, 2025 | Robb Gary Charles Officer (Chief Business Officer) | Gift | +1,000 | — | — |
| Mar 10, 2025 | Daniel N. Swisher Jr. Director | Option exercise | +2,200 | $12.13 | $26,686 |
| Mar 10, 2025 | Daniel N. Swisher Jr. Director | Open-market sale | −2,200 | $53.60 | $117,920 |
| Mar 4, 2025 | Guyer William Officer (Chief Development Officer) | Option exercise | +20,000 | $19.26 | $385,200 |
| Mar 4, 2025 | Guyer William Officer (Chief Development Officer) | Open-market sale | −20,000 | $59.07 | $1,181,400 |
| Mar 3, 2025 | Maduck Sean Officer (See Remarks) | Shares withheld for tax | −228 | $60.58 | $13,812 |
Reviews (0)
Sign in to write a review.
No reviews yet. Be the first to write one.